LONDON (Alliance News) - Midatech Pharma PLC said Wednesday it expects to meet market expectations for 2018 after increasing half-year revenue year-on-year.
For the six months to June 30, the pharmaceutical company said it expects gross product revenue of GBP5.8 million, a 16% increase on the GBP5.0 million reported for the same period last year.
The company added that two of its clinical trials for its key oncology drug candidates continue to progress well.
Midatech shares were trading down 1.8% at 28.00 pence each.